PAH-induced metabolic changes related to inflammation in childhood asthma

Hao Wu1, Yuling Bao2, Tongtong Yan1

  • 1Center for Global Health, School of Public Health and Department of Health Inspection and Quarantine, Nanjing Medical University, Nanjing, 211166, China.

Insights

Polycyclic aromatic hydrocarbons (PAHs) exposure impacts childhood asthma by disrupting one-carbon and tryptophan metabolism. PAHs alter DNA methylation and histone modifications, potentially increasing IL-17A levels and contributing to asthma development.

Area of Science:

  • Environmental Health
  • Molecular Toxicology
  • Pediatric Pulmonology

Background:

  • Epidemiological studies link polycyclic aromatic hydrocarbons (PAHs) to adverse childhood asthma outcomes.
  • The precise molecular mechanisms underlying PAH-induced asthma remain incompletely understood.
  • Investigating metabolic pathways, particularly one-carbon and tryptophan metabolism, is crucial for elucidating these mechanisms.

Purpose of the Study:

  • To investigate the molecular mechanisms by which PAHs affect childhood asthma.
  • To examine the roles of one-carbon metabolism and tryptophan metabolism in PAH-associated asthma.
  • To assess the mediating effects of metabolic intermediates, DNA methylation, and histone modifications.

Main Methods:

  • Recruitment of 50 asthmatic children and 50 controls.
  • Measurement of serum IgE, IL-17A, PAH concentrations (Fla), one-carbon metabolites, and tryptophan metabolites.
  • Analysis of DNA methylation, H3K4me3 enrichment, and gene expression in human samples and a PAH-exposed mouse model.

Main Results:

  • Serum Fla levels were associated with childhood asthma, significantly affecting one-carbon metabolites (SAH, SAM, Ser) and mediating the Fla-asthma relationship.
  • Significant mediation effects were observed between serum Fla and asthma via LINE-1 DNA methylation and H3K4me3 levels in the IL-17A promoter.
  • PAH exposure in mice altered the Trp metabolite-AhR-IL-17A axis, increasing methylation and potentially influencing Th17 cell differentiation.

Conclusions:

  • PAHs disrupt one-carbon metabolism, impacting DNA and histone methylation, which are linked to childhood asthma.
  • PAHs also disturb tryptophan metabolism, potentially regulating Th17 cell differentiation and increasing IL-17A levels in asthmatic children.
  • These metabolic disturbances represent key molecular pathways through which PAHs may contribute to childhood asthma pathogenesis.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
538
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
421
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K